Pharmacokinetic study of ardisiacrispin A in rat plasma after intravenous administration by UPLC-MS/MS
- Biomed Chromatogr. 2017 Mar;31(3). doi: 10.1002/bmc.3826.
- 1. Department of Hematology, The People's Hospital of Lishui, Lishui, 323000, China.
- 2. The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
- 3. Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui, 323000, China.
- 4. Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China.
- 5. Analytical and Testing Center, Wenzhou Medical University, Wenzhou, 325035, China.
- 6. The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
In this work, a sensitive and selective UPLC-MS/MS method for determination of ardisiacrispin A in rat plasma was developed. Cyasterone used as an internal standard (IS) and protein precipitation by acetonitrile-methanol (9:1, v/v) was used to prepare samples. Chromatographic separation was achieved on a UPLC BEH C18 column (2.1 × 100 mm, 1.7 μm) with 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. An electrospray ionization source was applied and operated in positive ion mode; multiple reaction monitoring mode was used for quantification using target fragment ions m/z 1083.5 → 407.1 for ardisiacrispin A and m/z 521.3 → 485.2 for IS. Calibration plots were linear throughout the range 5-2000 ng/mL for ardisiacrispin A in rat plasma. Mean recoveries of ardisiacrispin A in rat plasma ranged from 80.4 to 92.6%. The values of RSD of intra- and inter-day precision were both <11%. The accuracy of the method was between 97.3 and 105.6%. The method was successfully applied to pharmacokinetic study of ardisiacrispin A after intravenous administration in rats.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: AntibioticResearch Areas: Cancer